Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Risks for Insulin Resistance and Metabolic Syndrome (MS) Among Hospitalized Patients With Major Depressive Disorder With (MDpsy) or Without (MDD) Psychotic Features

NCT01310140 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01310140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01310140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Risks for Insulin Resistance and Metabolic Syndrome (MS) Among Hospitalized Patients With Major Depressive Disorder With (MDpsy) or Without (MDD) Psychotic Features
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Terminated
Start date
January 31, 2011
Completion date
September 30, 2012
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, major depressive disorder w/ psychotic features, metabolic syndrome